Clinigen Group plc (Clinigen) is a United-kingdom specialty pharmaceuticals and services business company. It operates in three segments: Clinical Trial Supply, Specialty Pharmaceuticals and Global Access Programs. Clinical Trial Supply (Clinigen CTS) sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies. Specialty Pharmaceuticals (Clinigen SP) manufactures and distributes its own and in-licensed specialist, hospital-only medicines across the world. Global Access Programs (Clinigen GAP) specializes in the consultancy, development, management and implementation of global access programs for biotechnology and pharmaceutical companies. It has added two oncology support products with the acquisition of Savene and Ethyol, together with Cardioxane bringing this portfolio to three and with the two anti-infectives (Foscavir and Vibativ), the total portfolio to five.